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Background. Common but seldom published are Parkinson’s disease (PD) medication errors involving late, extra, or missed doses.
These errors can reduce medication eﬀectiveness and the quality of life of people with PD and their caregivers. Objective.T o
explore lay perspectives of factors contributing to medication timing errors for PD in hospital and community settings. Designand
Methods. This qualitative research purposively sampled individuals with PD, or a proxy of their choice, throughout New Zealand
during2008-2009.Datacollectioninvolved20semistructured,personalinterviewsbytelephone.Ageneralinductiveanalysisofthe
data identiﬁed core insights consistent with the study objective. Results. Five themes help to account for possible timing adherence
errors by people with PD, their caregivers or professionals. The themes are the abrupt withdrawal of PD medication; wrong, vague
or misread instructions; devaluation of the lay role in managing PD medications; deﬁcits in professional knowledge and in caring
behavior around PD in formal health care settings; and lay forgetfulness. Conclusions. The results add to the limited published
research on medication errors in PD and help to conﬁrm anecdotal experience internationally. They indicate opportunities for
professionals and lay people to work together to reduce errors in the timing of medication for PD in hospital and community
settings.
1.Introduction
Medication-related errors are common [1], but not often
reported, in the treatment of Parkinson’s disease (PD), a
chronic and disabling neurodegenerative disorder whose
prevalence increases with age [2] and is likely to rise with
population aging. These errors can include the timing of
medication ingestion for PD [3]. Irregular timing, especially
of L-Dopa and in later stages of the disease [4], can adversely
aﬀect those who have PD, as well as their informal caregivers
[5]. Late, extra or missed doses can reduce medication
eﬃcacy—losing health gain, contributing to motor and non-
motorﬂuctuations[6]andimpairing functionandqualityof
life.
Timing errors for PD can take place in diverse health
settings. The need for people with PD to receive the right
medication at the right time in hospitals and care homes
underpins the “Get it on time” campaign of Parkinson’s
Societies internationally [7, 8]. Also common in community
settings are the missed and mistimed doses attributable in
whole or part to the (in) actions of people with PD and their
caregivers [9, 10]. This nonadherence has been reported to
result mainly from being “too busy/forget” or having “left
home without (the) drug” [9].
Approaches that health professionals use to identify and
measure their timing errors can include error reports, record
review, clinical surveillance, and observations of care [11].
However, people with PD, and their caregivers, can also
observe formal and informal care [12]; disclose their own
timing mistakes [13]; and share their error-related concerns
about professionals’ timing of medication for PD. Formal
safety assessments have tended to ignore lay errors and lay
perspectives [13]. Yet these perspectives link strongly to lay
satisfaction with the health care experience [14]. Also, they
“often reveal how well a hospital system is operating and
can stimulate important insights into the kinds of changes
that are needed to close the chasm between the care provided
and the care that should be provided” [15, page 33]. Health2 Parkinson’s Disease
professionals need to be aware of, and responsive to, these
perspectives if those who are most directly aﬀected by PD are
totrustthemandengageinprogramstoidentify,understand
and manage timing errors [13, 14].
The muted voices of patients and caregivers have con-
tributed to a paucity of research evidence on the nature and
signiﬁcance of the factors that can contribute in hospital
and community settings to actual or perceived errors around
medication timing for PD. Therefore, this paper seeks to
explore lay experience, understanding and perspectives of
these factors. It addresses this aim as part of our larger study
of medication-related errors in PD in New Zealand, whose
health system is funded from general taxation and includes
free or subsidised health care for those suﬀering from
chronic medical conditions. Ethics approval was obtained
from New Zealand’s multi-region health and disability ethics
committee.
2.MaterialsandMethods
2.1. Sampling. A sample was purposively selected of indi-
v i d u a l sw i t hP D ,w h ow e r es o m e t i m e sr e p r e s e n t e db ya
proxy of their choice, throughout New Zealand during
2008–2009. These volunteers had read an article published
by the researchers in the June 2008 issue of Parkinson’s
New Zealand’s quarterly magazine (The Parkinsonian), or
had been invited by one of its ﬁeld oﬃcers to consider
participating in the study. The volunteers had consented in
writing to give an interview and had reported, on a screening
questionnaire, that they, or the person on whose behalf they
were speaking, (a) had PD and (b) had “one or more stories
to tell about my experience of a possible mistake relating to
my medicine for Parkinson’s.”
2.2. Data Collection. Twenty semistructured, personal inter-
views were conducted by telephone. All the interviews were
conducted in English, mostly by JH but also SB. Participants
were asked to tell the interviewer about occasions when they
perceived having experienced possible mistakes with with
the medication prescribed for PD. The interviewer explored,
among other things, what the participants perceived to have
caused these mistakes. Each interview was audio-recorded,
with participants’ consent.
2.3. Data Analysis. Transcripts of the interviews were impo-
rted into QSR NVivo, a software programme for managing
and supporting the analysis of qualitative data. A general
inductive analysis of the data [16] was then used to identify
core meanings consistent with the study aim. This approach
involved closely reading and coding all the transcripts to
generateandreﬁneemergentthemes.Theotherauthorstook
the role of sceptical peer reviewers before the participants
were sent the analysis to check.
3. Results
Table 1 summarises the sample of 20 participants. Thirteen
had PD. Seven were proxies who spoke on behalf of a
person with PD. The interviews, therefore, referred to 20
people with PD, of whom 14 were male and 14 were aged
at least 65 years. Sixteen were reported to have PD of at
least moderate severity, and to have had a diagnosis of PD
for 11 years on average (standard deviation (s) = 5.6).
For 13 people with PD, the hospital was where a perceived
error with PD medication took place. The duration of the
interviews averaged 25.9 minutes (s = 10.9). Two potential
participants were excluded because they reported having
atypicalParkinson’s:LewyBodyDiseaseandMultipleSystem
Atrophy, respectively. Five salient themes were identiﬁed to
help explain possible timing adherence errors by people with
PD, their caregivers or professionals. Each theme is described
in turn.
3.1. Abrupt Withdrawal of PD Medication. Medication for
PD is not given on time when it is stopped deliberately and
abruptly. P12 described how the benign hallucinations of her
husband with PD worsened in hospital. She attributed this
sudden change to the morphine administered for his two
broken hips. However, the hospital was said to have ascribed
the exacerbation to his amantadine and “made him go cold
turkey.” Amantadine was reinstated, states P12, only when
she reminded staﬀ that the abrupt withdrawal of amantadine
could aggravate PD and its mental manifestations. Other
participants, such as P11, spoke of medication “omissions
for several days” in hospital, even though it is “imperative
that none of the Parkinson’s medications be halted.” No
participants reported a decision to suddenly discontinue any
PD medications themselves.
3.2. Instructions Wrong, Vague or Misread. P16 stated that
for two years her community pharmacy, despite “a lot of
the staﬀ changing all the time,” had dispensed two PD
medications (sinemet and entacapone) to her with the
labelled instruction: “Take six tablets once daily as directed.”
Recognising this instruction as a dangerous mistake, she
reported instead taking one tablet of each medicine every
three hours.
Other wrong instructions were said to have been given
in non-neurological, hospital wards through the mischarting
of dosing frequencies. According to P20, herself a practice
nurse, this error led to her father with PD receiving doses
at wrong times over two days. P12 also described how “the
charting would change (for her husband with PD) ...they
would have 8.00, 8.30 ...and I would say, “He is supposed to
get his pergolide on a full stomach.” “Oh, no, no, it’s charted
for ...”.
Othertimes, information was not wrong but misread:
“She (the House Surgeon) went back and said, “The nurse
has not read it (the chart). It is 1300 hours, not 3.00 at all””
(P12). P4 similarly indicated that hospital staﬀ “just glanced
down” at her partner’s chart, getting “in the routine of giving
him one without checking it thoroughly.” She reported that
the neurologist had assured her that the chart was correct,
and that “human error” accounted for her daily observation
that the sinemet dosage was short and given “late, anything
up to three-quarters of an hour.”
In community settings, however, the problem was some-
times the vagueness of dispensing instructions. P19 reportedParkinson’s Disease 3
Table 1: Participant attributes.
Participant Proxy Relationship to person with PD
∗ Person with PD
Age group Sex Self-rated PD severity Years with PD diagnosis
1N o < 65 Male Mild 5
2N o < 65 Male Severe 12
3N o < 65 Male Mild 9
4 Yes Partner < 65 Male Moderate 10
5N o < 65 Female Mild 4
6N o < 65 Female Mild 13
7 No 65–74 Male Moderate 18
8 No 65–74 Male Moderate 14
9 No 65–74 Male Moderate 10
10 Yes Wife 65–74 Male Moderate 3
11 No 65–74 Male Moderate 12
12 Yes Wife 65–74 Male Moderate 10
13 No 65–74 Male Moderate 14
14 No 65–74 Female Moderate 11
15 Yes Husband 65–74 Female Moderate 8
16 No 65–74 Female Moderate 8
17 Yes Partner 75+ Male Moderate 12
18 No 75+ Male Moderate 29
19 Yes Daughter 75+ Female Severe 7
20 Yes Daughter 75+ Male Moderate-severe 11
∗PD = Parkinson’s disease.
how her family had misunderstood instructions to take
a medication “four times a day.” They had thought this
indicated a need “to time the (Pd) medicine to four tablets
over 24 hours” even though this led to “big lows and big
highs” and interrupted their sleep for several months. On the
basis of the advice of the prescriber, the Parkinson’s Society
ﬁeld oﬃcer explained to the family that “you need to give
them during the daytime.”
3.3. Devaluation of the Lay Role. Several participants sug-
gested that hospital staﬀ wanted to take control of the PD
medications and did not seek or respect the insights or
perspective of the person with PD or their family. According
to P20, timing errors could have been avoided “if they
(hospital staﬀ) had only asked me (the caregiver)—I had
the latest script.” And when patients or caregivers oﬀer
information, “nobody listens, like you try and tell them
something and they think they know better all the time.”
This was despite people with PD having experience of what
worked best for them:“ ...if you are taking them everyday,
you know when you need to take them; your body tells you”
(P5), so ...“it is not really a sort of arranging it at the same
time every day” (P6).
It was felt that staﬀ commitments to change the timing
couldnot be relied upon: “they wouldsay, “oh yes,we willdo
that tomorrow” but it never happened” (P5). P8 concurred:
“They are good at talking on, rather than listening.” P4
added, “they did not like being corrected, any of them ...
I felt that they would have been happier if I had not been
there and chased them up on times.” Indeed, some staﬀ were
perceived to be patronising. P4 said that her partner with
PD “was dismissed” by a nurse who “was very abrupt and
ignored him and virtually walked oﬀ.” This was despite—
andperhapscontributedtoby—hisPDmakinghim“slightly
slower to respond” and asking of “him quite a bit of courage
tospeakout.”Anothercaregiver,P12,reportedthat“theywill
talk to him and they will ignore me.”
3.4. Lack of Both Professional Knowledge and Caring
Behaviour. Participants suggested that staﬀ “do not always
understand the way the (PD) medications work” (P6) and
“were not aware, I think, of the need for Parkinson people to
have their medication at a given time” (P9); they “regard the
times as a suggestion ...an indication of when you might get
them” (P12). P6 acknowledged that she was like them until
she developed PD: “I nursed a lot of them in the rest homes
andhospitalsthatIhaveworkedinandIwasnotawarereally
of the importance.” P9 added that staﬀ ‘admitted afterwards
that it was diﬀerent for them, having a Parkinson patient ...
and a big learning curve”.
“Part of the problem,” suggested P8, “is they are short
staﬀed ...they are rushing round all over the place ...and
medication times fall by the way side.” As a consequence,
added P12, “if they were busy, it (the charted times) did not
matter...and there was no check whether he (her husband)
took the pill”. P4, however, questioned the attribution to
staﬀ shortages: “there were numerous staﬀ standing around
... you could hear conversation and it was not medical
conversation ...it was more casual talk ...(so) it seems that
they could not have given a damn.”4 Parkinson’s Disease
3.5. Lay Forgetfulness. Timing errors were commonly also
ascribed to lay error, through people with PD, and their
caregivers: forgetting to administer the PD medication on
time,forexamplebecause“Iambusydoingsomething”(P8);
forgetting to use what reminds them (e.g., the timer) when
to take their medication; and forgetting “whether I have
taken it or not” (P3). These memory errors were reported to
take place only occasionally. Consequences included taking
late or extra doses of sinemet to manage motor ﬂuctuations
(and then adjusting the timing of the remaining doses) but
tending to miss the forgotten doses of other, less potent
antiparkinson medications: “I often do forget the ropinirole
and that is not such an issue ...Ij u s ts k i pt h a td o s e ”( P 5 )
and “I would suddenly think, “Oh, I forgot the amantadine
and the pergolide and it is now 3.30 p.m.; there is no point in
having it”” (P12).
4. Discussion
This qualitative paper has reported perspectives held by
people with PD, and their caregivers, around factors con-
tributing to possible medication timing errors for PD. Across
hospital and community settings, ﬁve sets of factors have
been identiﬁed, which add to the small amount of published
research on medication errors in PD. These results are likely
to be transferable to health systems similar to New Zealand,
since they conﬁrm anecdotal experience internationally
as well as policy and program responses that have been
introduced in the absence of research evidence.
PD medications were not given on time when abruptly
withdrawn. The United Kingdom’s National Institute for
Health and Clinical Excellence (NICE) guideline for man-
aging PD has highlighted the dangers of staﬀ suddenly
stopping antiparkinson medications [17]. Our paper has
illustrated why a reduction in treatment with a medication
such as amantadine must be gradual. Sudden withdrawal
can exacerbate the PD, producing, or worsening, cognitive
manifestations such as hallucinations.
Participants in this study described how instructions
for dispensing sometimes appeared wrong or vague. Their
reports are consistent with research on medication labelling
errors, such as wrong directions, by community pharmacies
[18–20], and on instructions for medication-taking that
can be “awkwardly phrased, vague, and unnecessarily dif-
ﬁcult” [21]. For example, P19 described how her family
had responded to a labelled instruction to administer PD
medication “four times a day”. The family had interpreted
this to mean a 24-hour period, which was not what the
prescriber had intended. However, it was reasonable for the
family to believe that timing adherence is not based only on
waking hours because “smoother symptom control results
from continuous, rather than pulsatile, drug delivery” [3].
The often high complexity of the medication regimen
therefore increases the need for clear instructions on when
to take the medication. Yet the regimen complexity and
the low health literacy of many lay people increase the
risk that vagueness will prevent them understanding the
intended meaning of labelled instructions [10]. Misreading
of instructions for the timing of PD medication was also
reported in this study to characterise hospital and care home
records and behaviour. This ﬁnding is consistent with the
“Get it on time” campaign [8] and with calls for physician
and pharmacist review of patient ward charts [22].
Some participants reported strugglingtohavetheir views
heard and valued in hospitals. Staﬀ were frequently said not
to respect the ability of lay people to choose to manage their
own medications for PD (even though the NICE guideline
supports this possibility) [17]. Areas of disagreement over
the lay role, and medication timing errors in PD by both
professionals and lay people, create an opportunity in all
health care settings for both parties to work together [23].
Many participants reported that people with PD, and
their caregivers, occasionally forget to take their PD med-
ication on time. The reasons they gave, such as busyness,
are consistent with their capacity to err, through lapses
in prospective memory [24]. Episodic information on the
timing of doses is, itself, subject to age-related memory loss
[25]. However, acting against forgetfulness are factors such
as wearing oﬀ and “on-oﬀ” phenomena, and the perceived
importance by lay people of administering PD medication
on time to relieve motor symptoms.
5. Strengths and Limitations
This study permitted people with PD, and their caregivers, to
represent their experience of issues around PD medication
mistiming and advocate for change. Lay people expect, and
are highly motivated to avoid, unsafe care delivery [23]a n d
are in the best position to assess and comment on their own
contributionstoerror.Theirperspectivesonmedicationtim-
ing errors can supplement those of professionals; elucidate
lay attitudes towards, and behaviour in, the health system;
and contribute to system-wide approaches to medication
error management.
Semistructured interviews by telephone were able to
elicit these perspectives in a manner that balanced the need
for a ﬂexible yet systematic approach to data collection.
Interviewing by telephone also collected data cost-eﬀectively
and quickly from a geographically dispersed, national sam-
ple. Telephone interviews are feasible with most people
with PD [26, 27] and the opportunity to involve proxies
minimised the loss of people with PD who ﬁnd telephone
use challenging.
However, this study has limitations. The sample is small,
but it provides in-depth information. Also, it “is biased; it
must be biased” [28] since purposive sampling was used
to select the most information-rich, lay participants. These
are the participants who can best represent the experience
of perceived medication errors by health professionals.
Unlike probability sampling, purposive sampling cannot
therefore represent the background population from which
participants were selected. We have, however, attempted to
provide suﬃcient information for readers to decide whether
our study ﬁndings are transferrable to their own settings.
In addition, when errors in medication timing in PD
become clinically important is not always clear [3]. Par-
ticipants’ reports in this study were subject to recall bias
and their nonclinical knowledge might have restricted theirParkinson’s Disease 5
ability to identify or attribute medication timing errors. No
attempt was made to verify the reports or assess cognitive
function;however ,ambulatory[29]andhospitalisedpatients
have the capacity to recognise medication errors [23]. Their
perspectives also deﬁne what is real to them. Another
limitation of our study is that the proxy reports may
diﬀer from the self-reports of the people with the medical
condition [30]. Errors in treatment timing initiation for PD
were outside the scope of this study.
6. Conclusions
The lay perspectives reported in this paper highlight oppor-
tunities from lived experience to reduce possible, avoidable
errors in the timing of medication ingestion for PD, and
attrition of health gain and quality of life. Further research
is needed to validate lay reports against external evidence
including the observations of professionals, and medical
records. However, the narratives reported in this study indi-
cate changes that may improve the timing of PD medication.
Such changes include eﬀective communication and shared
respect for the capacity of professionals and lay people to co-
manage PD medication delivery in hospital and community
settings. People with PD, and their caregivers, can contribute
to this partnership because they have experience of meeting
their own daily needs to manage PD, which professionals do
not have. Their lay knowledge can and should be enhanced
through a therapeutic alliance with health professionals,
which can reduce the risk that each party will err alone. This
shared care approach resonates with the NICE guideline [17]
and other United Kingdom initiatives, such as the expert
patientprogramme[31].Change,however,requiresaculture
shift. Progress will be halting until professionals recognise
the capacity of lay people to be involved in, and share
responsibility for, their PD care in diverse settings.
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